Healthcare101

 The global cell dissociation market in terms of revenue was estimated to be worth $0.6 billion in 2023 and is poised to reach $1.4 billion by 2028, growing at a CAGR of 17.8% from 2023 to 2028. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97548003 Cell dissociation Market Dynamics Driver: Increase in recombinant therapeutics sourced from mammalian cells The biopharmaceutical industry has witnessed a considerable increase in the proportion of recombinant therapeutics sourced from mammalian cells since 2002. The number of approved recombinant products from mammalian cell culture increased by 8.5% annually from 2002 to 2022. As of June 2022, more than 300 recombinant products have been commercialized, indicating a rapid shift towards mammalian-based therapeutics, which nearly account for 67% of therapeutics in 2022. .Cell culture products, including cell dissociation form an integral part of developing mammalian-based recombinant therapeutics, ...

  Cell Dissociation Market in terms of revenue was estimated to be worth $0.6 billion in 2023 and is poised to reach $1.4 billion by 2028, growing at a CAGR of 17.8% from 2023 to 2028 according to a new report by MarketsandMarkets™. Key drivers of the cell dissociation market include, growing use of tissue dissociation products in mammalian cell culture and expanding cell therapy production facilities. The mammalian-based capacity for recombinant proteins grew yearly at 10.8%, whereas recombinant microbial-based capacity grew at 3.0% yearly. As cell culture is an integral part of developing mammalian-based recombinant therapeutics, the uptake of cell dissociation products is expected to increase with it. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97548003 Browse in-depth TOC on " Collagenase Cell Dissociation Industry" 206 - Tables 37 - Figures 204 – Pages Enzymatic dissociation products accounted for the larger share of the cell ...

 The cell dissociation industry is expected to experience significant growth over the next few years, driven by advances in cell culture technology, the increasing use of stem cells in research and drug discovery, and the development of novel cell-based therapies. As the demand for high-quality cell dissociates grows, the industry can expect to see more investments in developing new cell dissociation techniques, such as single-cell isolation, nanotechnology-based cell disruption, and micropipette-based cell dissociation. Additionally, the development of new automation tools and technologies to improve consistency and efficiency of cell dissociation processes are expected to drive future growth. In the coming years, the industry can also expect to see advances in artificial intelligence and machine learning, which could further revolutionize the cell dissociation industry. Cell Dissociation Market in terms of revenue was estimated to be worth $0.6 billion in 2023 and is poised to ...

 According to the new market research report " Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes) - Global Forecast to 2026" The global cell dissociation market size is projected to reach USD 561 million by 2026 from USD 282 million in 2021, at a CAGR of 14.7%. The growth in this market is attributed to the prevalence of cell based research, the increasing number of pharmaceutical and biotechnology companies. Key Players: Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Cytiva (a part of Danaher Corporation) (US), STEMCELL Technologies (Canada), Miltenyi Biotec (Germany), and PromoCell GmbH (Germany) etc. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97548003 Browse in-depth TOC on " Cell Dissocia...